-+ 0.00%
-+ 0.00%
-+ 0.00%

NEWAMSTERDAM PHARMA AND MENARINI GROUP RECEIVE EUROPEAN COMMISSION APPROVAL FOR UBESLO® (OBICETRAPIB MONOTHERAPY) AND EVLARCO® (OBICETRAPIB PLUS EZETIMIBE FIXED-DOSE COMBINATION)

Reuters·09/21/2026 13:00:04

Please log in to view news